Arm C

DRUG6 trials

Conditions

Breast CancerCancerLeprosy, Buruli Ulcer and Lymphatic Filariasis Mental and Behavioural Disorders Skin and Connective Tissue DiseasesMetastasis, NeoplasmTuberculosisTuberculosis RespiratoryType 2 Diabetes

Phase 1

A HR20031 BE Study on Healthy Subjects

CompletedNCT05682495

Shandong Suncadia Medicine Co., Ltd.Type 2 Diabetes

Start: 2023-01-31End: 2023-04-04Updated: 2023-04-07

Phase 2

Docetaxel and Cisplatin Chemotherapy With or Without High Dose Proton Pump Inhibitor in Metastatic Breast Cancer

CompletedNCT01069081

Fudan UniversityBreast Cancer, Metastasis, Neoplasm

Start: 2009-08-31End: 2012-02-29Updated: 2015-03-06

StatinTB Trial

RecruitingPACTR202211865409139

University of Cape TownTuberculosis Respiratory

Start: 2020-07-01Target: 342Updated: 2026-08-03

Platform Assessing Regimens And Durations In a Global Multisite Consortium for TB [PARADIGM4TB (UNITE4TB – 01)]

Active, not recruitingPACTR202403493915530

University College LondonTuberculosis

Start: 2024-04-15Target: 2500Updated: 2026-08-03

Phase 3

A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer (ProHer)

RecruitingPACTR202211579014330

Hoffmann La RocheCancer

Start: 2022-07-05Target: 330Updated: 2026-08-03

Unknown Phase

LIVEX PROJECT

Active, not recruitingPACTR202404852537141

EFFECT HOPE CANADALeprosy, Buruli Ulcer and Lymphatic Filariasis Mental and Behavioural Disorders Skin and Connective Tissue Diseases

Start: 2022-10-01Target: 200Updated: 2026-08-03

Related Papers

Reassessing the Significance of Mycobacterium in Neglected Tropical Diseases: A Study Protocol in Nigeria

International Journal of Mycobacteriology2024-10-01

Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancer.

2015-08-22120 citations